Sec Form 13G Filing - Morningside Venture Investments Ltd filing for NewAmsterdam Pharma Co N.V. (NAMS) - 2023-09-19

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G/A

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

NEWAMSTERDAM PHARMA COMPANY N.V.

(Name of Issuer)

Ordinary Shares, nominal value EUR 0.12 per share

(Title of Class of Securities)

N62509109

(CUSIP Number)

September 11, 2023

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. N62509109

 

  1.    

  Names of Reporting Persons

 

  Morningside Venture Investments Limited

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☒         (b)  ☐

 

  3.  

  SEC Use Only

 

  4.  

  Citizenship or Place of Organization

 

  British Virgin Islands

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With

   5.     

  Sole Voting Power

 

  0

   6.   

  Shared Voting Power

 

  4,060,923

   7.   

  Sole Dispositive Power

 

  0

   8.   

  Shared Dispositive Power

 

  4,060,923

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  4,060,923

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row (9)

 

  4.93% (1)

12.  

  Type of Reporting Person (See Instructions)

 

  CO

 

(1)

Based upon 82,324,331 shares of Ordinary Shares outstanding as of June 30, 2023, as reported in the Issuer’s Form 6-K filed with the Securities and Exchange Commission (the “SEC”) on August 7, 2023.

 

2


CUSIP No. N62509109

 

  1.    

  Names of Reporting Persons

 

  Frances Anne Elizabeth Richard

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☒         (b)  ☐

 

  3.  

  SEC Use Only

 

  4.  

  Citizenship or Place of Organization

 

  United Kingdom

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With

   5.     

  Sole Voting Power

 

  0

   6.   

  Shared Voting Power

 

  4,060,923

   7.   

  Sole Dispositive Power

 

  0

   8.   

  Shared Dispositive Power

 

  4,060,923

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  4,060,923

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row (9)

 

  4.93% (1)

12.  

  Type of Reporting Person (See Instructions)

 

  IN

 

(1)

Based upon 82,324,331 shares of Ordinary Shares outstanding as of June 30, 2023, as reported in the Issuer’s Form 6-K filed with the SEC on August 7, 2023.

 

3


CUSIP No. N62509109

 

  1.    

  Names of Reporting Persons

 

  Jill Marie Franklin

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☒         (b)  ☐

 

  3.  

  SEC Use Only

 

  4.  

  Citizenship or Place of Organization

 

  United Kingdom

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With

   5.     

  Sole Voting Power

 

  0

   6.   

  Shared Voting Power

 

  4,060,923

   7.   

  Sole Dispositive Power

 

  0

   8.   

  Shared Dispositive Power

 

  4,060,923

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  4,060,923

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row (9)

 

  4.93% (1)

12.  

  Type of Reporting Person (See Instructions)

 

  IN

 

(1)

Based upon 82,324,331 shares of Ordinary Shares outstanding as of June 30, 2023, as reported in the Issuer’s Form 6-K filed with the SEC on August 7, 2023.

 

4


CUSIP No. N62509109

 

  1.    

  Names of Reporting Persons

 

  Peter Stuart Allenby Edwards

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☒         (b)  ☐

 

  3.  

  SEC Use Only

 

  4.  

  Citizenship or Place of Organization

 

  United Kingdom

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With

   5.     

  Sole Voting Power

 

  0

   6.   

  Shared Voting Power

 

  4,060,923

   7.   

  Sole Dispositive Power

 

  0

   8.   

  Shared Dispositive Power

 

  4,060,923

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  4,060,923

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row (9)

 

  4.93% (1)

12.  

  Type of Reporting Person (See Instructions)

 

  IN

 

(1)

Based upon 82,324,331 shares of Ordinary Shares outstanding as of June 30, 2023, as reported in the Issuer’s Form 6-K filed with the SEC on August 7, 2023.

 

5


CUSIP No. N62509109

 

  1.    

  Names of Reporting Persons

 

  Cheung Ka Ho

  2.  

  Check the Appropriate Box if a Member of a Group (See Instructions)

  (a)  ☒         (b)  ☐

 

  3.  

  SEC Use Only

 

  4.  

  Citizenship or Place of Organization

 

  Hong Kong

Number of

Shares

  Beneficially  

Owned by

Each

Reporting

Person

With

   5.     

  Sole Voting Power

 

  0

   6.   

  Shared Voting Power

 

  4,060,923

   7.   

  Sole Dispositive Power

 

  0

   8.   

  Shared Dispositive Power

 

  4,060,923

  9.    

  Aggregate Amount Beneficially Owned by Each Reporting Person

 

  4,060,923

10.  

  Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

  ☐

11.  

  Percent of Class Represented by Amount in Row (9)

 

  4.93% (1)

12.  

  Type of Reporting Person (See Instructions)

 

  IN

 

(1)

Based upon 82,324,331 shares of Ordinary Shares outstanding as of June 30, 2023, as reported in the Issuer’s Form 6-K filed with the SEC on August 7, 2023.

 

6


CUSIP No. N62509109

 

Item 1.

 

(a)   

Name of Issuer

 

NewAmsterdam Pharma Company N.V.

 

 

 

(b)   

Address of Issuer’s Principal Executive Offices

 

Gooimeer 2-35, 1411 DC Naarden, The Netherlands

 

Item 2.

 

(a)   

Name of Person Filing
Morningside Venture Investments Limited

Frances Anne Elizabeth Richard

Jill Marie Franklin

Peter Stuart Allenby Edwards

Cheung Ka Ho

(b)   

Address of Principal Business Office or, if none, Residence
c/o THC Management Services S.A.M.

2nd Floor, Le Prince De Galles

3-5 Avenue Des Citronniers

MC 98000, Monaco

 

With copies to:

 

Morningside Technology Advisory, LLC

Attn: Stephanie O’Brien, Esq.

1188 Centre Street

Newton Centre, MA 02459

 

Springfield Financial Advisory Limited

Attn: Investment Administration Department

22nd Floor Hang Lung Centre

2-20 Paterson Street

Causeway Bay, Hong Kong

(c)    Citizenship
Morningside Venture Investments Limited    British Virgin Islands
Frances Anne Elizabeth Richard    United Kingdom
Jill Marie Franklin    United Kingdom
Peter Stuart Allenby Edwards    United Kingdom
Cheung Ka Ho    Hong Kong

 

(d)   

Title of Class of Securities

 

Ordinary Shares, nominal value EUR 0.12 per share

(e)   

CUSIP Number

 

N62509109

 

7


CUSIP No. N62509109

 

Item 3.

If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

 

(a)       Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)       Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)       Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)       Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)       An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)       An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)       A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
(h)       A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)       A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)       A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
(k)       Group, in accordance with §240.13d–1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:

 

Item 4.

Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

(a)   

Amount beneficially owned:

 

Morningside Venture Investments Limited – 4,060,923

Frances Anne Elizabeth Richard – 4,060,923

Jill Marie Franklin – 4,060,923

Peter Stuart Allenby Edwards – 4,060,923

Cheung Ka Ho – 4,060,923

(b)   

Percent of class:

 

Morningside Venture Investments Limited – 4.93%

Frances Anne Elizabeth Richard – 4.93%

Jill Marie Franklin – 4.93%

Peter Stuart Allenby Edwards – 4.93%

Cheung Ka Ho – 4.93%

(c)    Number of shares as to which the person has:
   (i)   

Sole power to vote or to direct the vote

Morningside Venture Investments Limited – 0 shares

Frances Anne Elizabeth Richard – 0 shares

Jill Marie Franklin – 0 shares

Peter Stuart Allenby Edwards – 0 shares

Cheung Ka Ho – 0 shares

 

8


CUSIP No. N62509109

 

(ii)   

Shared power to vote or to direct the vote

Morningside Venture Investments Limited – 4,060,923 shares

Frances Anne Elizabeth Richard – 4,060,923 shares

Jill Marie Franklin – 4,060,923 shares

Peter Stuart Allenby Edwards – 4,060,923 shares

Cheung Ka Ho – 4,060,923 shares

(iii)   

Sole power to dispose or to direct the disposition of

Morningside Venture Investments Limited – 0 shares

Frances Anne Elizabeth Richard – 0 shares

Jill Marie Franklin – 0 shares

Peter Stuart Allenby Edwards – 0 shares

Cheung Ka Ho – 0 shares

(iv)   

Shared power to dispose or to direct the disposition of

Morningside Venture Investments Limited – 4,060,923 shares

Frances Anne Elizabeth Richard – 4,060,923 shares

Jill Marie Franklin – 4,060,923 shares

Peter Stuart Allenby Edwards – 4,060,923 shares

Cheung Ka Ho – 4,060,923 shares

 

 

This statement is filed by: (i) Morningside Venture Investments Limited, a British Virgin Islands exempted company (“MVIL”), with respect to the Ordinary Shares directly and beneficially owned by it; (ii) Frances Anne Elizabeth Richard, with respect to the Ordinary Shares beneficially owned by her as a result of her position as a director with MVIL; (iii) Jill Marie Franklin, with respect to the Ordinary Shares beneficially owned by her as a result of her position as a director with MVIL; (iv) Peter Stuart Allenby Edwards, with respect to the Ordinary Shares beneficially owned by him as a result of his position as a director with MVIL; and (v) Cheung Ka Ho, with respect to the Ordinary Shares beneficially owned by him as a result of his position as a director with MVIL; (Each of the foregoing is referred to as a “Reporting Person” and collectively as the “Reporting Persons”). Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards, and Cheung Ka Ho are the directors of MVIL and share voting and dispositive power with respect to the securities held by MVIL. Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim beneficial ownership of the securities held by MVIL. MVIL is ultimately wholly beneficially owned by a trust over which Adriel Wenbwo Chan and Wong Yuk Lan share authority to remove the trustee.

 

Item 5.

Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ☒.

 

Item 6.

Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

 

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not applicable.

 

Item 8.

Identification and Classification of Members of the Group

The information set forth in Item 2 is incorporated herein by reference.

 

9


CUSIP No. N62509109

 

Item 9.

Notice of Dissolution of Group

Not applicable.

 

Item 10.

Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

 

10


 

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. We also hereby agree to file this statement jointly pursuant to the Agreement listed on Exhibit 99.1 hereto.

Dated: September 19, 2023

 

For and on behalf of:
MORNINGSIDE VENTURE INVESTMENTS LIMITED
By:  

/s/ Frances Anne Elizabeth Richard

  Frances Anne Elizabeth Richard

/s/ Frances Anne Elizabeth Richard

Frances Anne Elizabeth Richard

/s/ Cheung Ka Ho

Cheung Ka Ho

/s/ Jill Marie Franklin

Jill Marie Franklin

/s/ Peter Stuart Allenby Edwards

Peter Stuart Allenby Edwards

 

11